X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9) 9
index medicus (8) 8
oncology (6) 6
adult (5) 5
cancer (5) 5
female (5) 5
hematology, oncology and palliative medicine (5) 5
male (5) 5
multiple myeloma (5) 5
multiple myeloma - drug therapy (5) 5
stem-cell transplantation (5) 5
care and treatment (4) 4
analysis (3) 3
bone marrow (3) 3
bortezomib (3) 3
chemotherapy (3) 3
combination (3) 3
middle aged (3) 3
therapy (3) 3
transplants & implants (3) 3
treatment outcome (3) 3
adolescent (2) 2
age (2) 2
aged (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
biopsy (2) 2
boronic acids - adverse effects (2) 2
dexamethasone (2) 2
dexamethasone - administration & dosage (2) 2
drug resistance (2) 2
drugs (2) 2
experiment (2) 2
flow cytometry (2) 2
gastroenterology & hepatology (2) 2
hepatitis b, chronic - drug therapy (2) 2
high energy physics (2) 2
high-dose chemotherapy (2) 2
lamivudine (2) 2
leukemia (2) 2
medical research (2) 2
neoplasm staging (2) 2
particle physics (2) 2
peripheral nervous system diseases - chemically induced (2) 2
peripheral neuropathy (2) 2
physics (2) 2
prognosis (2) 2
prospective studies (2) 2
pyrazines - adverse effects (2) 2
quality of life (2) 2
refractory myeloma (2) 2
risk assessment (2) 2
risk factors (2) 2
salvage therapy (2) 2
thalidomide - adverse effects (2) 2
thalidomide - analogs & derivatives (2) 2
toxicity (2) 2
young adult (2) 2
accumulation (1) 1
acute lymphoblastic leukemia (1) 1
acute lymphocytic leukemia (1) 1
alanine transaminase - blood (1) 1
alpha sarcoglycan (1) 1
alpha-2a (1) 1
alternative splicing (1) 1
angiogenesis inhibitors - adverse effects (1) 1
antifolate resistance (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antitumor activity (1) 1
antitumor-activity (1) 1
antiviral agents - administration & dosage (1) 1
apoptosis (1) 1
astrophysics (1) 1
aurora a kinase (1) 1
beyond standard model (1) 1
blotting, western (1) 1
bone marrow transplantation (1) 1
bone-marrow (1) 1
carmustine - administration & dosage (1) 1
carnitine palmitoyltransferase 1c (1) 1
carnitine palmitoyltransferase i (1) 1
caspase 9 (1) 1
caspase-9 (1) 1
cccdna (1) 1
cd32 antigen (1) 1
cell cycle (1) 1
cell-lines (1) 1
cern lhc coll (1) 1
chi-square distribution (1) 1
child (1) 1
chronic hepatitis b (1) 1
circulating plasma-cells (1) 1
cisplatin - administration & dosage (1) 1
clinical trials (1) 1
coding (1) 1
combined modality therapy (1) 1
competing risks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. e328 - e346
Journal Article
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 11, pp. 1057 - 1065
Summary Background Bortezomib-induced peripheral neuropathy is a dose-limiting toxicity in patients with multiple myeloma, often requiring adjustment of... 
Hematology, Oncology and Palliative Medicine | APOPTOSIS | DEXAMETHASONE | EFFICACY | ONCOLOGY | REFRACTORY MYELOMA | PHASE-II | INDUCTION | STEM-CELL TRANSPLANTATION | NEUROTOXICITY | CANCER | LINES | Peripheral Nervous System Diseases - chemically induced | Prospective Studies | Humans | Middle Aged | Boronic Acids - adverse effects | Gene Expression Profiling | Young Adult | Multiple Myeloma - drug therapy | Time Factors | Antineoplastic Agents - adverse effects | Adult | Odds Ratio | Peripheral Nervous System Diseases - genetics | Genetic Predisposition to Disease | Bortezomib | Multiple Myeloma - diagnosis | Risk Assessment | Europe | Gene Frequency | Risk Factors | Treatment Outcome | Chi-Square Distribution | Adolescent | Pyrazines - adverse effects | Vincristine - adverse effects | Aged | Polymorphism, Single Nucleotide | Neoplasm Staging | Multiple Myeloma - genetics | Antimitotic agents | Care and treatment | Antineoplastic agents | Analysis | Multiple myeloma | Toxicity | Clinical trials | Nervous system | Superoxide dismutase | Single-nucleotide polymorphism | Myeloma | Peripheral neuropathy | DNA repair | Mitochondria | Coding | Cell cycle | Peripheral blood | Age | Peripheral nervous system | Enzymes | Excretion | Data processing | Inflammation | Gene expression | Metabolism | Vincristine | Quality of life | Queens | Caspase-9 | Plasma cells | Peroxisome proliferator-activated receptors | Apoptosis | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 11, pp. 1055 - 1066
Journal Article
Journal of High Energy Physics (Online), ISSN 1029-8479, 05/2018, Volume 2018, Issue 11
JHEP 11 (2018) 042 A search in energetic, high-multiplicity final states for evidence of physics beyond the standard model, such as black holes, string balls,... 
Physics - High Energy Physics - Experiment | Beyond Standard Model | Hadron-Hadron scattering (experiments) | PHYSICS OF ELEMENTARY PARTICLES AND FIELDS
Journal Article
04/2018
JINST 13 (2018) P06015 The CMS muon detector system, muon reconstruction software, and high-level trigger underwent significant changes in 2013-2014 in... 
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/1995, Volume 333, Issue 23, pp. 1540 - 1545
Journal Article
The Lancet, ISSN 0140-6736, 1992, Volume 340, Issue 8814, pp. 255 - 259
Resistance to chemotherapy in refractory multiple myeloma is frequently associated with expression of multidrug resistance (MDR). In resistant cells,... 
Cyclosporine | Drug therapy | Drug resistance | Health aspects | Multiple myeloma | Drugs | Medical research | Cancer
Journal Article
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.